期刊文献+

基因的单核苷酸多态性与乳腺癌关系的研究进展 被引量:1

Research Progress on the Correlation of Single Nucleotide Polymorphism of Genes with Breast Cancer
原文传递
导出
摘要 乳腺癌是女性发病率最高的恶性肿瘤,具有家族聚集性,其发生发展是一个复杂的过程,涉及多种不同基因的相互作用和相互调控。随着基因技术和分子生物技术的飞速发展,许多基因被揭示在乳腺癌的发生发展中起关键作用,如BRCA、FGFR、ATM、ZNF365、Pokemon基因等。基于流行病学研究,这些易感基因可被分为高外显率易感基因和低外显率易感基因,其多态性对乳腺癌具有重要的影响。对乳腺癌易感基因的研究有助于阐明乳腺癌的发生机制、发展过程,对其早期诊断、预后判断和良恶性鉴别也有着重要的意义,可为乳腺癌的临床生物基因靶向治疗提供新的靶点和理论基础。本文主要对这些基因的单核苷酸多态性与乳腺癌关系的研究进展进行了综述。 Breast cancer has the highest incidence of female cancers. Breast cancer shows familial aggregation and its development is a complex process, involving the interaction of different genes and their regulation. With the rapid development of gene technology and molecular biological technology, many of the genes were revealed to play a key role in the occurrence of breast cancer,including BRCA, FGFR, ATM, ZNF365, Pokemon gene, etc. Based on the epidemiological studies, the susceptible genes can be divided into high penetrance and low penetrance susceptible genes. Susceptible genes greatly influence the breast cancer. Researches on the identification of susceptibility genes of breast cancer will deeply contribute to clarify its pathogenesis, development, early diagnosis,prognosis, and benign and malignant, and also provide new targets and theoretical basis for the clinical biological gene targeted therapy.Therefore, research on breast cancer susceptible gene is of great significance to the development of medicine, and the susceptible gene detection has received more and more attention of the researchers. This article mainly reviews the correlation of single nucleotide polymorphism of these susceptible genes with breast Cancer.
出处 《现代生物医学进展》 CAS 2014年第22期4382-4385,共4页 Progress in Modern Biomedicine
基金 国家自然基金面上项目(31371290) 广东省高校人才引进专业(粤财字2011-430)
关键词 单核苷酸多态性 乳腺癌 BRCA FGFR ATM ZNF365 POKEMON SNP Breast cancer BRCA FGFR ATM ZNF365 Pokemon
  • 相关文献

参考文献20

  • 1Martin DB, Nelson PS. From genomics to proteomics: techniques and applications 'in cancer research[J]. Trends Cell Bioi, 2001, 11 (11): S60-65.
  • 2Michailidou K, Hall P, Gonzalez-Neira A, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk[J]. Nat Genet, 2013, 45(4): 353-361, 361el-2.
  • 3Bernstein JL, Thomas DC, Shore RE, et al. WECARE Study Collaborative Group. Contralateral breast cancer after radiotherapy among BRCAI and BRCA2 mutation carriers: a WECARE study report[J]. Eur J Cancer, 2013, 49(14): 2979-2985.
  • 4Bosviel R, Durif J, De chelotte P, et al. Epigenetic modulation of BRCAI and BRCA2 gene expression by equol in breast cancer cell lines[J]. Br J Nutr, 2012,108(7): 1187-1193.
  • 5Metcalfe KA, Finch A, Poll A, et al. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCAI or BRCA2 mutation[J]. Br J Cancer, 2009, 100(2): 421-425.
  • 6Fackenthal JD, Zhang J, Zhang B, et al. High prevalence of BRCAI and BRCA2 mutations in unselected Nigerian breast cancer patients[J]. IntJCancer, 2012, 131(5): 1114-1123.
  • 7Liska F, Gosele C, Popova E, et al. Overexpression of full-length centrobin rescues limb malformation but not mexpression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic ale fertility of the hypodactylous (hd) rats[J]. PLoS One, 2013, 8(4): e60859.
  • 8Baumann P, Benson FE, West Sc. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro[J]. Cell, 1996,87(4): 757-766.
  • 9Huang C, Huang R, Chang W, et al. The adenocarcinoma[J]. Neoplasma, 2012,59(1): 52-61.
  • 10Garcia M, Pole JC, Chin SF, et al. A 1 Mb minimal amplicon at 8pll-12 in breast cancer identifies new candidate oncogenes[J]. Oncogene, 2005, 24(33): 5235-5245.

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部